Showing 1591-1600 of 2727 results for "".
- Viewpoints: Recent CoolSculpting Media Coverage: Observations and Clarificationshttps://modernaesthetics.com/news/viewpoints-recent-coolsculpting-media-coverage-observations-and-clarifications/2473160/As an aesthetic key opinion leader, and longtime member of the Editorial Board of Modern Aesthetics® magazine, I would like to add observations and clarifications regarding some of the recent attention to CoolSculpting in the news. CoolSculpting is a technology that was d
- Soliton Appoints Aesthetic Executive Veteran Brad Hauser as President and CEO in Preparation for Commercial Launchhttps://modernaesthetics.com/news/soliton-appoints-aesthetic-executive-veteran-brad-hauser-as-president-and-ceo-in-preparation-for-commercial-launch/2473013/Soliton, Inc., has named Brad A. Hauser as President and Chief Executive Officer of Soliton. He most recently served as Vice President, R&D and General Manager for CoolSculpting at Allergan Aesthetics, an AbbVie Company, since Allergan's
- Neothetics, Inc.'s Stock Tumbles Following "Unambiguous" Negative LIPO-202 Resultshttps://modernaesthetics.com/news/neothetics-incs-stock-tumbles-following-unambiguous-negative-lipo-202-results/2472217/Neothetics, Inc.’s LIPO-202 for the reduction of submental subcutaneous fat failed to demonstrate improvement on any efficacy measurements or separation from placebo in a Phase 2 proof-of-concept trial. Neothetics Inc. shares d
- Nearly 10.5 Million Treatments Performed by ASDS Members in 2016https://modernaesthetics.com/news/nearly-105-million-treatments-performed-by-asds-members-in-2016/2472226/Dermatologic surgeons performed nearly 10.5 million medically necessary and cosmetic procedures in 2016 – five percent more than 2015 and up 31 percent since 2012, according to the 2016 American Society for Dermatologic Surgery (ASDS) Survey on D
- Review Examines Dermatologic Effects of Rapid Weight Losshttps://modernaesthetics.com/news/review-examines-dermatologic-effects-of-rapid-weight-loss/2486984/Rapid weight loss associated with bariatric surgery, glucagon-like peptide-1 receptor agonists (GLP-1 RA), and intensive lifestyle interventions may contribute to dermatologic and structural changes that extend beyond reduced body size, according to a narrative rev
- Dr. Kevin Pinski Presents Injectable Pearls at Noahhttps://modernaesthetics.com/news/dr-kevin-pinski-presents-injectable-pearls-at-noah/2486902/At the 67th Noah Worcester Dermatological Society Annual Meeting, Kevin Pinski, MD, presented “Injectable Pearls,” drawing on nearly 4 decades of experience with neuromodulators, fillers, and cosmetic injectables. The presentation covered practical techniques, pati
- Dermalogica Enters Device Market With FDA-Cleared Microneedling Systemhttps://modernaesthetics.com/news/dermalogica-enters-device-market-with-fda-cleared-microneedling-system/2486887/Dermalogica has announced the launch of its PRO Pen Microneedling System following US Food and Drug Administration (FDA) 510(k) clearance, marking the company’s first entry into the medical device category. The device is indicated for the treatment of facial acne scars in adults aged 22 years and
- 12-Month Data Support Durability of Click-Crosslinked HA for Nasolabial Foldhttps://modernaesthetics.com/news/12-month-data-support-durability-of-click-crosslinked-ha-for-nasolabial-fold/2486822/A novel long-chain hyaluronic acid (HA) filler utilizing click-chemistry crosslinking demonstrated sustained efficacy and a favorable safety profile for nasolabial fold (NLF) correction in 2 prospective studies published in the Journal of Cosmetic Dermatology. Traditional HA fille
- Revance Highlights RHA Dynamic Volume Mid-Face FDA Approval at Virtual Desk Sidehttps://modernaesthetics.com/news/revance-highlights-rha-dynamic-volume-mid-face-fda-approval-at-virtual-desk-side/2486819/Revance Aesthetics hosted a virtual desk side with Lesley Clark-Loeser, MD, to discuss the recent US Food and Drug Administration (FDA) approval of RHA Dynamic Volume for cheek augmentation and correction of age-related mid-face contour deficiencies in adults aged 22 years and older. The a
- SkinCeuticals Launches Future Mineral UV Defense SPF 50 for Daily and Post-Procedure Usehttps://modernaesthetics.com/news/skinceuticals-launches-future-mineral-uv-defense-spf-50-for-daily-and-post-procedure-use/2486804/SkinCeuticals has introduced Future Mineral UV Defense SPF 50, a new mineral sunscreen designed to provide broad-spectrum UV protection while also addressing visible signs of skin aging, according to the company. The formulation combines 15% zinc oxide and 3% titanium dioxide and is intend